Continuous renal replacement therapy for severe acute renal failure

Abstract

Abstract: Objective To estimate the clinical value of continuous renal replacement therapy (CRRT) in the treatment of severe acute renal failure (ARF) and identify the factors influencing the patients’ prognosis. Methods The clinical characteristics, disease severity and prognosis were retrospectively studied in 116 patients with severe ARF undergoing CRRT from January, 1998 to May, 2004, in comparison with those in 102 such patients treated with intermittent hemodialysis (IHD). Results The mean score of Acute Physiology and Chronic Health Evaluation II (APACHE II) was 27.0±7.5 in patients receiving CRRT, of whom 56 (48%) had a score no less than 29, 36 (31%) between 24 to 29 and 24 (21%) less than 24. The mean APACHE II score was 21.9±5.2 in patients with IHD, and none of them had a score over 29, 44 (43%) had a score between 24 to 29 and 58 (57%) less than 24. The mean APACHE II score of CRRT group was significantly higher than that of IHD group (t=4.769, P=0.000), suggesting that most of the patients treated with CRRT were in critical condition. The patients’ survival rate, however, did not differ significantly between the two groups, being 37% (43/116) in CRRT group and 48% (49/102) in IHD group (χ²=2.678, P=0.101 8). When only the patients with a score no less than 24 were compared, the survival rate of CRRT group was significantly higher than that of IHD group (24% vs 9%, χ² =4.229, P=0.039 7), demonstrating better effect of CRRT than IHD in the management of critical ARF cases. In patients treated with CRRT, the patients in fatal cases had significantly older age, more critical condition (indicated by APACHE II score) and greater dependence on mechanical ventilation or vasoactive support than those who survived (P<0.05). Conclusions CRRT is one of the effective methods for management of severe ARF patients, especially in those with critical conditions, with better effect than that of IHD. The prognosis of severe ARF patients treated with CRRT can be influenced by the patients’ age and disease severity, and the need of vasoactive drugs or mechanical ventilation may help predict the patients’ prognosis.

CLC Number:

R692.5

SHAO Yong-hong¹, HUANG Ying-wei¹, KONG Yao-zhong¹, ZHOU Li-xin², LIN Min-wa¹, XIAO Guang-qing¹. Continuous renal replacement therapy for severe acute renal failure[J]. Journal of Southern Medical University, 2004, 24(12): 1388-1390.

References

[1] 季大玺,谢红浪,黎磊石,等.连续性肾脏替代疗法在重症急性肾功能衰竭治疗中的应用[J].中华内科杂志,1999,38(12):802-5.Ji DX, Xie HL, Li LS, et al. Treatment of severe acute renal failure with continuous renal replacement therapy [J]. Chin J Intern Med,1999, 38(12): 802-5.
[2] Kellum JA, Angus DC, Johnson JP, et al. Continuous versus intermittent renal replacement therapy: ameta-analysis [J]. Intensive Care Med, 2002, 28(1): 29-37.
[3] Swartz RD, Messana JM, Orzol S, et al. Comparing continuous hemofiltration with hemodialysis in patients with severe acute renal failure1 [J]. Am J Kidney Dis, 1999, 34(3): 424-32.
[4] Guerin C, Girard R, SelliJ M, et al. Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care units: Results from a multicenter prospective epidemiological survey[J]. Intensive Care Med, 2002, 28(10): 1411-8.
[5] 叶任高,谢桐.急性肾功能衰竭诊断标准[J].新医学(New Med),1983,14(1):2-5.
[6] 肖观清,黄英伟,邵咏红,等.连续性血液净化中不同配方置换液的疗效比较[J].内科急危重症杂志,2002,8(3):126-8Xiao GQ, Huang YW, Shao YH, et al. Comparison of the efficacy of different prescriptions for replacement fluids in continuous blood purification[J]. Crit Emerg Intern Med, 2002, 8(3): 126-8.
[7] Manna M, Sigler MH, Teehan BP. Continuous renal replacement therapies: an update[J]. Am J Kidney Dis, 1998, 32(2): 185-207.
[8] Bellom R, Boyce N. Continuous venous hemodiafiltration compared with conventional dialysis in critically ill patients with acute renal failure[J]. ASAIO J, 1993, 9(3): M794-7.
[9] Brivet FG, Kleinknecht DJ, Loirat P, et al. Acute renal failure in intensive care units: causes, outcomes and prognostic factors of hospital mortality: a prospective, multicenter study[J]. Crit Care Med, 1996, 24(1):192-8.